BIOPRO Baden-Württemberg GmbH and their French network partner BioValley France organise their 16th joint «Meet & Match» event. Focussing on «Precision Medicine – Research, Diagnostics & Therapy», the event takes place on Tuesday, July 2, 2019, in Stuttgart.
Thematically, the focus of this networking event is on present and future trends in the field of Precision Medicine such as biomarker/target identification, big data, single cell analysis as well as novel diagnostic and therapeutic approaches, e.g. in the area of individualised cancer treatment or cell therapies.
Prof. Dr. Nisar Malek, speaker of the Centre for Personalised Medicine (ZPM) in Tübingen, will open the event with a keynote on current advances in the field. In addition, 10 presentations from researchers and industry will provide insights into ongoing projects and trends related to Precision Medicine.
The Meet & Match addresses research institutions and companies – from Baden-Württemberg and the French region Grand Est – with an interest in Precision Medicine, biotechnology, diagnostics and drug development. The objective is to establish new contacts, encourage participants to initiate cooperations or joint developments as well as to gain a better understanding of Precision Medicine and its possible applications. The lunch and coffee breaks offer extensive networking opportunities.
During the «Short presentation session» participants may introduce their company or research group to enable intense networking opportunities. You can apply for a two-minute short presentation upon registration until Friday, June 7, 2019. Please note that the number of short presentations is limited and that the session is arranged for research institutions or companies being active in R&D or production. Selection is made by the organisers.
The participation is free of charge. Prior registration is requested. The event will be held in English.
We look forward to seeing you in Stuttgart!
Keynote:Prof. Dr. Nisar Malek, Dept. of Internal Medicine and Center for Personalized Medicine, University Hospital Tübingen | Germany«Status quo and future of Personalised Medicine»
Dr. Eric Quemeneur, Transgene S.A., Illkirch-Graffenstaden | France«Individualised viral vector-based immunotherapy for cancer treatment, the myvac™ approach»
Dr. Christian Schmees, NMI Natural and Medical Sciences Institute at the University of Tübingen | Germany«Project PRIMO – Linking novel approaches of personalised medicine and digitisation for tailor-made cancer therapies»
Prof. Dr. Seiamak Bahram, Strasbourg Hospital | France«Precision Medicine in immune-mediated diseases»
Dr. Mona Boyé, KSILINK, Strasbourg | France«Patient-based drug discovery – an integrated approach from bed to bench to bed cycle»
Dr. Tobias Paprotka, Eurofins Genomics Europe (formerly: GATC Biotech AG), Freiburg | Germany«NGS applications − from oncology to tuberculosis detection»
Dr. Wolgang Huber, European Molecular Biology Laboratory (EMBL), Heidelberg | Germany«Multi-omics data integration and ex-vivo drug perturbations for disease stratification in blood cancers»
Dr. Marcus Dühren-von Minden, AVA Lifescience GmbH, Denzlingen | Germany«CAR-T cell – Beauty or Beast»
Dr. Dr. Saskia Biskup, CeGaT GmbH, Tübingen | Germany«Current methods for genetic diagnostics towards individualized cancer vaccines»
Dr. Alain Wagner, MicroOmiX, Illkirch | France«Single Cell Secretomic – the next next frontier in the dynamic tumor heterogeneity?»
Marcus Kowalczyk, Cell Prothera, Mulhouse | France«Development of a technology platform for distributed production in autologous cell therapy application»